Hospital Administrator, Memorial Health System
For over 30 years, the federal 340B Drug Pricing Program has enabled millions of Americans, including our patients in Abilene, to access essential healthcare. This program allows hospitals and clinics to purchase medications at a discount, ensuring that vulnerable populations—including seniors on fixed incomes and low-income families—can access vital services like chemotherapy, diabetes care, and behavioral health.
Unfortunately, pharmaceutical companies are increasingly undermining the 340B Program to boost profits, prioritizing investors over patients. In 2022 alone, Kansas 340B hospitals faced a combined net revenue loss of $18.2 million, while the top eight drug companies earned $99.4 billion…